Global Needle-Free Drug Delivery Systems Market Research Report 2021

Publisher Name :
Date: 18-Feb-2021
No. of pages: 120
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Jet-based

- Spring-based

- Laser-based

Segment by Application

- Hospital

- Clinic

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Antares Pharma

- Pharmajet

- Optinose

- Valeritas

- Crossject

- Injex Pharma

- 3M Pharmaceuticals

- Becton Dickinson (BD)

- MedImmune

- Mystic Pharmaceuticals

- Zogenix

Global Needle-Free Drug Delivery Systems Market Research Report 2021

Table of Contents
1 Needle-Free Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Needle-Free Drug Delivery Systems
1.2 Needle-Free Drug Delivery Systems Segment by Type
1.2.1 Global Needle-Free Drug Delivery Systems Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Jet-based
1.2.3 Spring-based
1.2.4 Laser-based
1.3 Needle-Free Drug Delivery Systems Segment by Application
1.3.1 Needle-Free Drug Delivery Systems Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Needle-Free Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Needle-Free Drug Delivery Systems Revenue 2016-2027
1.4.2 Global Needle-Free Drug Delivery Systems Sales 2016-2027
1.4.3 Needle-Free Drug Delivery Systems Market Size by Region: 2016 Versus 2021 Versus 2027
2 Needle-Free Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Needle-Free Drug Delivery Systems Sales Market Share by Manufacturers (2016-2021)
2.2 Global Needle-Free Drug Delivery Systems Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Needle-Free Drug Delivery Systems Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Needle-Free Drug Delivery Systems Manufacturing Sites, Area Served, Product Type
2.5 Needle-Free Drug Delivery Systems Market Competitive Situation and Trends
2.5.1 Needle-Free Drug Delivery Systems Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Needle-Free Drug Delivery Systems Players Market Share by Revenue
2.5.3 Global Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Needle-Free Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Needle-Free Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Needle-Free Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.3.1 North America Needle-Free Drug Delivery Systems Sales by Country
3.3.2 North America Needle-Free Drug Delivery Systems Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.4.1 Europe Needle-Free Drug Delivery Systems Sales by Country
3.4.2 Europe Needle-Free Drug Delivery Systems Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Needle-Free Drug Delivery Systems Market Facts & Figures by Region
3.5.1 Asia Pacific Needle-Free Drug Delivery Systems Sales by Region
3.5.2 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Latin America Needle-Free Drug Delivery Systems Sales by Country
3.6.2 Latin America Needle-Free Drug Delivery Systems Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country
3.7.2 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Needle-Free Drug Delivery Systems Historic Market Analysis by Type
4.1 Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2016-2021)
4.2 Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2016-2021)
4.3 Global Needle-Free Drug Delivery Systems Price by Type (2016-2021)
5 Global Needle-Free Drug Delivery Systems Historic Market Analysis by Application
5.1 Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2016-2021)
5.2 Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2016-2021)
5.3 Global Needle-Free Drug Delivery Systems Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Antares Pharma
6.1.1 Antares Pharma Corporation Information
6.1.2 Antares Pharma Description and Business Overview
6.1.3 Antares Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Antares Pharma Product Portfolio
6.1.5 Antares Pharma Recent Developments/Updates
6.2 Pharmajet
6.2.1 Pharmajet Corporation Information
6.2.2 Pharmajet Description and Business Overview
6.2.3 Pharmajet Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pharmajet Product Portfolio
6.2.5 Pharmajet Recent Developments/Updates
6.3 Optinose
6.3.1 Optinose Corporation Information
6.3.2 Optinose Description and Business Overview
6.3.3 Optinose Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Optinose Product Portfolio
6.3.5 Optinose Recent Developments/Updates
6.4 Valeritas
6.4.1 Valeritas Corporation Information
6.4.2 Valeritas Description and Business Overview
6.4.3 Valeritas Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Valeritas Product Portfolio
6.4.5 Valeritas Recent Developments/Updates
6.5 Crossject
6.5.1 Crossject Corporation Information
6.5.2 Crossject Description and Business Overview
6.5.3 Crossject Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Crossject Product Portfolio
6.5.5 Crossject Recent Developments/Updates
6.6 Injex Pharma
6.6.1 Injex Pharma Corporation Information
6.6.2 Injex Pharma Description and Business Overview
6.6.3 Injex Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Injex Pharma Product Portfolio
6.6.5 Injex Pharma Recent Developments/Updates
6.7 3M Pharmaceuticals
6.6.1 3M Pharmaceuticals Corporation Information
6.6.2 3M Pharmaceuticals Description and Business Overview
6.6.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 3M Pharmaceuticals Product Portfolio
6.7.5 3M Pharmaceuticals Recent Developments/Updates
6.8 Becton Dickinson (BD)
6.8.1 Becton Dickinson (BD) Corporation Information
6.8.2 Becton Dickinson (BD) Description and Business Overview
6.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Becton Dickinson (BD) Product Portfolio
6.8.5 Becton Dickinson (BD) Recent Developments/Updates
6.9 MedImmune
6.9.1 MedImmune Corporation Information
6.9.2 MedImmune Description and Business Overview
6.9.3 MedImmune Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.9.4 MedImmune Product Portfolio
6.9.5 MedImmune Recent Developments/Updates
6.10 Mystic Pharmaceuticals
6.10.1 Mystic Pharmaceuticals Corporation Information
6.10.2 Mystic Pharmaceuticals Description and Business Overview
6.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Mystic Pharmaceuticals Product Portfolio
6.10.5 Mystic Pharmaceuticals Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Corporation Information
6.11.2 Zogenix Needle-Free Drug Delivery Systems Description and Business Overview
6.11.3 Zogenix Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Zogenix Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
7 Needle-Free Drug Delivery Systems Manufacturing Cost Analysis
7.1 Needle-Free Drug Delivery Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Needle-Free Drug Delivery Systems
7.4 Needle-Free Drug Delivery Systems Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Needle-Free Drug Delivery Systems Distributors List
8.3 Needle-Free Drug Delivery Systems Customers
9 Needle-Free Drug Delivery Systems Market Dynamics
9.1 Needle-Free Drug Delivery Systems Industry Trends
9.2 Needle-Free Drug Delivery Systems Growth Drivers
9.3 Needle-Free Drug Delivery Systems Market Challenges
9.4 Needle-Free Drug Delivery Systems Market Restraints
10 Global Market Forecast
10.1 Needle-Free Drug Delivery Systems Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Needle-Free Drug Delivery Systems by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Needle-Free Drug Delivery Systems by Type (2022-2027)
10.2 Needle-Free Drug Delivery Systems Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Needle-Free Drug Delivery Systems by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Needle-Free Drug Delivery Systems by Application (2022-2027)
10.3 Needle-Free Drug Delivery Systems Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Needle-Free Drug Delivery Systems by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Needle-Free Drug Delivery Systems by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Needle-Free Drug Delivery Systems Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Needle-Free Drug Delivery Systems Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Needle-Free Drug Delivery Systems Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Needle-Free Drug Delivery Systems Covered in This Study
Table 5. Global Needle-Free Drug Delivery Systems Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Needle-Free Drug Delivery Systems Sales Share by Manufacturers (2016-2021)
Table 7. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Needle-Free Drug Delivery Systems Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Needle-Free Drug Delivery Systems Manufacturing Sites and Area Served
Table 11. Manufacturers Needle-Free Drug Delivery Systems Product Type
Table 12. Global Needle-Free Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Needle-Free Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Needle-Free Drug Delivery Systems as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Needle-Free Drug Delivery Systems Sales by Region (2016-2021) & (K Units)
Table 16. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 17. Global Needle-Free Drug Delivery Systems Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Needle-Free Drug Delivery Systems Sales by Country (2016-2021) & (K Units)
Table 19. North America Needle-Free Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 20. North America Needle-Free Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 22. Europe Needle-Free Drug Delivery Systems Sales by Country (2016-2021) & (K Units)
Table 23. Europe Needle-Free Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 24. Europe Needle-Free Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Needle-Free Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Needle-Free Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Needle-Free Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Table 30. Latin America Needle-Free Drug Delivery Systems Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Needle-Free Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 32. Latin America Needle-Free Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Needle-Free Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Needle-Free Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 38. Global Needle-Free Drug Delivery Systems Sales (K Units) by Type (2016-2021)
Table 39. Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 40. Global Needle-Free Drug Delivery Systems Revenue (Million US$) by Type (2016-2021)
Table 41. Global Needle-Free Drug Delivery Systems Revenue Share by Type (2016-2021)
Table 42. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Type (2016-2021)
Table 43. Global Needle-Free Drug Delivery Systems Sales (K Units) by Application (2016-2021)
Table 44. Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 45. Global Needle-Free Drug Delivery Systems Revenue (Million US$) by Application (2016-2021)
Table 46. Global Needle-Free Drug Delivery Systems Revenue Share by Application (2016-2021)
Table 47. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Application (2016-2021)
Table 48. Antares Pharma Corporation Information
Table 49. Antares Pharma Description and Business Overview
Table 50. Antares Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Antares Pharma Needle-Free Drug Delivery Systems Product
Table 52. Antares Pharma Recent Developments/Updates
Table 53. Pharmajet Corporation Information
Table 54. Pharmajet Description and Business Overview
Table 55. Pharmajet Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Pharmajet Needle-Free Drug Delivery Systems Product
Table 57. Pharmajet Recent Developments/Updates
Table 58. Optinose Corporation Information
Table 59. Optinose Description and Business Overview
Table 60. Optinose Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Optinose Needle-Free Drug Delivery Systems Product
Table 62. Optinose Recent Developments/Updates
Table 63. Valeritas Corporation Information
Table 64. Valeritas Description and Business Overview
Table 65. Valeritas Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Valeritas Needle-Free Drug Delivery Systems Product
Table 67. Valeritas Recent Developments/Updates
Table 68. Crossject Corporation Information
Table 69. Crossject Description and Business Overview
Table 70. Crossject Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Crossject Needle-Free Drug Delivery Systems Product
Table 72. Crossject Recent Developments/Updates
Table 73. Injex Pharma Corporation Information
Table 74. Injex Pharma Description and Business Overview
Table 75. Injex Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Injex Pharma Needle-Free Drug Delivery Systems Product
Table 77. Injex Pharma Recent Developments/Updates
Table 78. 3M Pharmaceuticals Corporation Information
Table 79. 3M Pharmaceuticals Description and Business Overview
Table 80. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product
Table 82. 3M Pharmaceuticals Recent Developments/Updates
Table 83. Becton Dickinson (BD) Corporation Information
Table 84. Becton Dickinson (BD) Description and Business Overview
Table 85. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product
Table 87. Becton Dickinson (BD) Recent Developments/Updates
Table 88. MedImmune Corporation Information
Table 89. MedImmune Description and Business Overview
Table 90. MedImmune Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. MedImmune Needle-Free Drug Delivery Systems Product
Table 92. MedImmune Recent Developments/Updates
Table 93. Mystic Pharmaceuticals Corporation Information
Table 94. Mystic Pharmaceuticals Description and Business Overview
Table 95. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product
Table 97. Mystic Pharmaceuticals Recent Developments/Updates
Table 98. Zogenix Corporation Information
Table 99. Zogenix Description and Business Overview
Table 100. Zogenix Needle-Free Drug Delivery Systems Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Zogenix Needle-Free Drug Delivery Systems Product
Table 102. Zogenix Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Needle-Free Drug Delivery Systems Distributors List
Table 106. Needle-Free Drug Delivery Systems Customers List
Table 107. Needle-Free Drug Delivery Systems Market Trends
Table 108. Needle-Free Drug Delivery Systems Growth Drivers
Table 109. Needle-Free Drug Delivery Systems Market Restraints
Table 110. Global Needle-Free Drug Delivery Systems Sales Forecast by Type (2022-2027) & (K Units)
Table 111. Global Needle-Free Drug Delivery Systems Sales Market Share Forecast by Type (2022-2027)
Table 112. Global Needle-Free Drug Delivery Systems Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 113. Global Needle-Free Drug Delivery Systems Revenue Market Share Forecast by Type (2022-2027)
Table 114. Global Needle-Free Drug Delivery Systems Sales Forecast by Application (2022-2027) & (K Units)
Table 115. Global Needle-Free Drug Delivery Systems Sales Market Share Forecast by Application (2022-2027)
Table 116. Global Needle-Free Drug Delivery Systems Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 117. Global Needle-Free Drug Delivery Systems Revenue Market Share Forecast by Application (2022-2027)
Table 118. Global Needle-Free Drug Delivery Systems Sales Forecast by Region (2022-2027) & (K Units)
Table 119. Global Needle-Free Drug Delivery Systems Sales Market Share Forecast by Region (2022-2027)
Table 120. Global Needle-Free Drug Delivery Systems Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 121. Global Needle-Free Drug Delivery Systems Revenue Market Share Forecast by Region (2022-2027)
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Needle-Free Drug Delivery Systems
Figure 2. Global Needle-Free Drug Delivery Systems Market Share by Type in 2020 & 2027
Figure 3. Jet-based Product Picture
Figure 4. Spring-based Product Picture
Figure 5. Laser-based Product Picture
Figure 6. Global Needle-Free Drug Delivery Systems Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Needle-Free Drug Delivery Systems Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Needle-Free Drug Delivery Systems Market Size 2016-2027 (US$ Million)
Figure 12. Global Needle-Free Drug Delivery Systems Sales 2016-2027 (K Units)
Figure 13. Global Needle-Free Drug Delivery Systems Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Needle-Free Drug Delivery Systems Sales Share by Manufacturers in 2020
Figure 15. Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Needle-Free Drug Delivery Systems Players: Market Share by Revenue in 2020
Figure 17. Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2016-2021)
Figure 19. Global Needle-Free Drug Delivery Systems Sales Market Share by Region in 2020
Figure 20. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Figure 21. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region in 2020
Figure 22. U.S. Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Needle-Free Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Needle-Free Drug Delivery Systems by Type (2016-2021)
Figure 47. Sales Market Share of Needle-Free Drug Delivery Systems by Application (2016-2021)
Figure 48. Sales Market Share of Needle-Free Drug Delivery Systems by Application in 2020
Figure 49. Revenue Share of Needle-Free Drug Delivery Systems by Application (2016-2021)
Figure 50. Revenue Share of Needle-Free Drug Delivery Systems by Application in 2020
Figure 51. Manufacturing Cost Structure of Needle-Free Drug Delivery Systems
Figure 52. Manufacturing Process Analysis of Needle-Free Drug Delivery Systems
Figure 53. Needle-Free Drug Delivery Systems Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs